Nutex Health reports FY2022 revenue of $219.3M, net loss of $424.8M on $398.1M goodwill impairment

Nutex Health Inc.

Total revenue $219.3M for FY2022; Q4 revenue $53.7M; net loss attributable to Nutex $424.8M.
Adjusted EBITDA $12.5M for FY2022; Q4 adjusted EBITDA loss of $5.9M.
Net cash from operating activities $50.6M; cash and equivalents $34.3M at year-end.
Goodwill impairment of $398.1M; warrant/option valuation revision reduced impairment by $10.3M.
No Surprises Act reduced revenue by ~$29M in Q3 and $9.6M in H1 2022; company plans 19 new facilities by mid-2025.

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

Nutex Health Inc. reported the fiscal year ended December 31, 2022 results: revenue $219.3 million, net income Net loss attributable to Nutex Health Inc. of $424.8 million.

Period: the fiscal year ended December 31, 2022
Revenue: $219.3 million
Net income: Net loss attributable to Nutex Health Inc. of $424.8 million
Result: reported results

Exact text from the filing

99.1 to this Current Report on Form 8-K. --- EX-99.1 (EX-99.1) --- NUTEX HEALTH Inc. reports fourth quarter and Full YEAR 2022 financial results ● Total revenue of $219.3 million for the year ended 2022 ● Net cash from operating activities of $50.6 million for the YEAR ended 2022 ● Company expects to open 19 NEW facilities by mid-2025 HOUSTON, TX −

View on SEC.gov

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

Nutex Health Inc. reported the three months ended December 31, 2022 results: revenue $53.7 million, net income Net loss attributable to Nutex Health of $14.7 million.

Period: the three months ended December 31, 2022
Revenue: $53.7 million
Net income: Net loss attributable to Nutex Health of $14.7 million
Result: reported results

Exact text from the filing

Financial Highlights for the Three Months Ended December 31, 2022: ● Total revenue of $53.7 million. ● Net loss attributable to Nutex Health of $14.7 million.

View on SEC.gov

Browse all earnings releases →

Nutex Health Inc. filing history →

Source: SEC EDGAR

accession 0001558370-23-002711

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.